Article
Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case
Rating:
0.0
Views:
70
Likes:
1
Library:
1
A Delaware jury on Friday ordered Illumina Inc to pay more than $333 million to a U.S. unit of Chinese genomics company BGI Group after finding that Illumina's DNA-sequencing systems infringed two patents.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value